Androgen substitution treatment (ART), frequently refered to as testosterone substitution treatment (TRT), is a type of chemical treatment, wherein androgens, frequently testosterone, are supplanted. In order to combat the effects of male hypogonadism, ART is frequently prescribed. Typically, testosterone is administered via injection, skin cream, patch, gel, or subcutaneous pellet form. Testosterone replacement therapy is a promising technology for improving symptoms of hypogonadism and to raise the testosterone level. Furthermore, benefits related to application of testosterone replacement therapy include an increase in muscle tissue, overall surge in energy, and significant decrease in depression symptoms.
Market Dynamics
The androgen replacement therapy market is expected to witness growth during the forecast period, owing to the increasing mergers and acquisitions among pharmaceutical companies. For instance, in October 2022, Tolmar Inc., a U.S-based pharmaceutical research, development, manufacturing and commercial operations company, announced the acquisition of all rights to JATENZO, an oral softgel testosterone medicine from Clarus Therapeutics Holdings, Inc. and its wholly-owned subsidiary Clarus Therapeutics, Inc.- a pharmaceutical company with specialization in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. following a public auction.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook